Breakout coming soon Price is ready to break 90$ resistance (light blu line) !
A large GAP is also waiting to be filled above 90$
I think everything is ready to push price up
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.330 CHF
523.30 M CHF
3.66 B CHF
386.62 M
About DexCom, Inc.
Sector
Industry
CEO
Kevin Ronald Sayer
Website
Headquarters
San Diego
Founded
1999
FIGI
BBG00LVD7CL3
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
DXCM DexCom Options Ahead of EarningsAnalyzing the options chain and the chart patterns of DXCM DexCom prior to the earnings report this week,
I would consider purchasing the 90usd strike price Calls with
an expiration date of 2025-2-21,
for a premium of approximately $1.65.
If these options prove to be profitable prior to the earnings
BreakoutPrice finally breaking out of green channel up
A lot of GAPs are waiting to be filled upward
$DXCM - Breaking Out Now! 46% Upside!Chart #20/ 40: NASDAQ:DXCM 🏥
-Symmetrical Triangle Breakout with breakdown Retest
-H5 Indicator is Green
-Williams Consolidation Box Support Created
-AVP Shelf to launch off with Massive VOLUME GAP
🎯$110📏 $91 ⏳ Before APR2025
NFA
DXCM LongLong on Diabetes. Diabetes will only get worse as we continue to eat garbage everyday. Fib level.
DXCM Long Swing Analysis
DXCM offers a compelling swing trade setup, with a strong base forming over the past 4 months around a critical support zone of $74–$68. Following a drop on July 2024 earnings, the stock remains resilient, supported by robust revenue figures and, in my view, a superior CGM product tha
Dexcom Inc. 1. Company Overview and Industry Growth Potential
Dexcom Inc. is a prominent player in the medical technology industry, focusing on continuous glucose monitoring (CGM) systems primarily used by individuals with diabetes. The company's flagship product line, the Dexcom G Series, offers real-time glu
5 Shades of Grey!DXCM 5 shades of grey;
First started in May 2020 when this area of around 107 continues tocomeback whether it be to consolidate, trend, or reverse 3 pivot points found, fast forward to the 2nd shade of grey when in February 2021 the stock came back as a double top.
The 3rd shade started a year a
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
DXCM5195221
DexCom, Inc. 0.25% 15-NOV-2025Yield to maturity
5.47%
Maturity date
Nov 15, 2025
DXCM5813816
DexCom, Inc. 0.375% 15-MAY-2028Yield to maturity
3.98%
Maturity date
May 15, 2028
See all DC4 bonds
Related stocks
Frequently Asked Questions
The current price of DC4 is 50.516 CHF — it has decreased by −35.76% in the past 24 hours. Watch DEXCOM INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange DEXCOM INC stocks are traded under the ticker DC4.
DC4 stock has fallen by −35.76% compared to the previous week, the month change is a −35.76% fall, over the last year DEXCOM INC has showed a −54.11% decrease.
We've gathered analysts' opinions on DEXCOM INC future price: according to them, DC4 price has a max estimate of 97.95 CHF and a min estimate of 65.30 CHF. Watch DC4 chart and read a more detailed DEXCOM INC stock forecast: see what analysts think of DEXCOM INC and suggest that you do with its stocks.
DC4 stock is 56.29% volatile and has beta coefficient of 1.13. Track DEXCOM INC stock price on the chart and check out the list of the most volatile stocks — is DEXCOM INC there?
Today DEXCOM INC has the market capitalization of 22.39 B, it has decreased by −10.91% over the last week.
Yes, you can track DEXCOM INC financials in yearly and quarterly reports right on TradingView.
DEXCOM INC is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
DC4 earnings for the last quarter are 0.41 CHF per share, whereas the estimation was 0.44 CHF resulting in a −6.10% surprise. The estimated earnings for the next quarter are 0.29 CHF per share. See more details about DEXCOM INC earnings.
DEXCOM INC revenue for the last quarter amounts to 1.01 B CHF, despite the estimated figure of 1.01 B CHF. In the next quarter, revenue is expected to reach 900.66 M CHF.
DC4 net income for the last quarter is 137.77 M CHF, while the quarter before that showed 114.06 M CHF of net income which accounts for 20.79% change. Track more DEXCOM INC financial stats to get the full picture.
No, DC4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 10.3 K employees. See our rating of the largest employees — is DEXCOM INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DEXCOM INC EBITDA is 742.63 M CHF, and current EBITDA margin is 20.28%. See more stats in DEXCOM INC financial statements.
Like other stocks, DC4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DEXCOM INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DEXCOM INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DEXCOM INC stock shows the strong sell signal. See more of DEXCOM INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.